(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Copaxone: Solution for injection (40mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

GLATIRAMER (gla TIR a mer) helps to decrease the number of multiple sclerosis relapses in people with relapsing-remitting forms of the disease. The medicine does not cure multiple sclerosis.

In-Depth Information

Copaxone Pre-Filled Syringe 40mg/ml Solution for Injection

NDC: 685460325
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Sclerosis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Do not use if product has been frozen
May be stored at room temperature for up to 1 month
Protect from extreme heat
Do not freeze
Copaxone Pre-Filled Syringe 40mg/ml Solution for Injection

Reported Side Effects for Copaxone Pre-Filled Syringe 40mg/ml Solution for Injection

Skin Necrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: EARLY
Hostility Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Enlarged Liver Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Of Blood Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Hallucinations Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Bone Pain Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Aborted Pregnancy Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Throat Ulcers Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Rash Of Red Skin Bumps Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Slow Heart Beat Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: RAPID
Eosinophilia Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Cyanosis Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: EARLY
Blistery Rash Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Increase In Breast Size Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Incoordination Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Unable To Speak Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Cholecystitis Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Memory Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Vesicular Rash Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Tongue Discoloration Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Tenesmus Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Striae Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Removal Of Spleen Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Drooping Eyelids Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Priapism Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Photosensitivity Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: RAPID
Paresthesias Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Paranoia Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Pancytopenia Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Sores Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Nighttime Urination Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Rapid Muscle Twitches Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Large Pupil Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Melena Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Decreased Healing Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Cataracts Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Bleeding Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Dry Eyes Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Underactive Thyroid Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Coma Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: EARLY
Serum Sickness Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Optic Nerve Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Allergic Skin Reaction Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Psoriasis Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Cushing's Syndrome Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Boils Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Gout Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Light Sensitivity Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Enlarged Thyroid Gland Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Thinning Of Skin Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
0.1-8.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Throat Inflammation Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Disease Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Colon Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Overactive Thyroid Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: RAPID
High Blood Pressure Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Vaginal Bleeding Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Emotional Lability Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
>1.0%*
Severity: SEVERE
Onset: EARLY
Heavy Menstrual Period Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Fecal Urgency Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
2.0-43.0%*
Severity: MODERATE
Onset: EARLY
Difficulty Swallowing Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.0-15.0%*
Severity: MILD
Onset: EARLY
Vocal Cord Spasm Incidence:
2.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
2.0-13.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
2.0-3.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
2.0-19.0%*
Severity: MILD
Onset: EARLY
Peripheral Vasodilation Incidence:
3.0-20.0%*
Severity: MODERATE
Onset: RAPID
Shortness Of Breath Incidence:
3.0-14.0%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
3.0%*
Severity: MILD
Onset: RAPID
Weight Gain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
3.0-14.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
4.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
5.0-27.0%*
Severity: MILD
Onset: RAPID
Urinary Urgency Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
5.0%*
Severity: MODERATE
Onset: RAPID
Cough Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Excessive Sweating Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
8.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
9.0%*
Severity: MODERATE
Onset: EARLY
Sore Throat Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
12.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
22.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
30.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Copaxone

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.